Company: DNLI
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001714899-25-000170
Chunk: 405

Company: Denali Therapeutics Inc.
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 8
Chunk 405
---
020 $52,452 $— $1,143,472 The Company’s Level 2 securities are valued using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly.The Company has not transferred any assets or liabilities between the fair value measurement levels for the six months ended June 30, 2025 or for the year ended December 31, 2024.

11

3.    Marketable Securities

All marketable securities were considered available-for-sale at June 30, 2025 and December 31, 2024. On a recurring basis, the Company records its marketable securities at fair value using Level 1 or Level 2 inputs as discussed in Note 2, "Fair Value Measurements". The amortized cost, gross unrealized holding gains or losses, and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):June 30, 2025Amortized CostUnrealized Holding GainsUnrealized Holding LossesAggregate Fair ValueShort-term marketable securities:U.S. government treasuries$719,188 $1,014 $(71)$720,131 Corporate debt securities37,498 116 — 37,614 Total short-term marketable securities756,686 1,130 (71)757,745 Long-term marketable securities:U.S. government treasuries66,664 188 — 66,852 Corporate debt securities11,568 43 — 11,611 Total long-term marketable securities78,232 231 — 78,463 Total$834,918 $1,361 $(71)$836,208 December 31, 2024Amortized CostUnrealized Holding GainsUnrealized Holding LossesAggregate Fair ValueShort-term marketable securities:U.S. government treasuries$627,809 $1,618 $(27)$629,400 Corporate debt securities21,337 62 — 21,399 Commercial paper6,572 — — 6,572 Total short-term marketable securities655,718 1,680 (27)657,371 Long-term marketable securities:U.S. government treasuries334,300 788 (196